Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Human Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem / Stromal Cells (hMSCs)
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Resources

Scalable, Continuous, & High-capacity Production of hMSC-derived Extracellular Vesicles in the Scale-X™ Hydro Fixed-bed Bioreactor

July 05, 2023 Educational Material, Whitepaper

Donor-Specific Angiogenic Effects of MSCs in 3D Microvascular Tissue Constructs

March 21, 2023 Whitepaper

3D Manufacturing of Therapeutic hMSCs with RoosterNourish™-XF & beadMATRIX

September 28, 2022 Whitepaper

Development of an Optimized Lentiviral Transduction Medium & Process to Manufacture Genetically Modified MSC Working Cell Banks

June 09, 2022 Poster

Optimization of Transient Transfection of Mesenchymal Stromal Cells with Plasmid DNA or Messenger RNA for Cell Therapy

June 09, 2022 Poster

Scale-Up of a Xeno-Free Fed-Batch Stirred-Tank Bioreactor Process for hMSC Manufacturing

June 09, 2022 Poster

Developing a Microcarrier Stirred Tank Process for Large-Scale hMSC-EV Production

June 09, 2022 Poster

Are hMSCs a Platform of Choice for Gene Engineered Cellular Therapy?

June 24, 2021 Infographic

Development of an Optimized Lentiviral Transduction Medium and Process to Manufacture Genetically Modified MSC Working Cell Banks

May 19, 2021 Poster

eBook: Genome Editing of MSCs

May 03, 2021 eBook
Previous 1 2 3 4 5 6 Next

Sidebar Navigation

  • Educational Material
    • Brochure
    • Case Study
    • eBook
    • Infographic
    • Poster
    • Whitepaper
  • Product Documentation
    • Product Sheet
    • Protocol
    • Safety Data Sheet
    • Schematic

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email